Showing 4119 results for "als"

GM604 for ALS

GM604 is an experimental therapy designed to slow disease progression in people with ALS. It was developed by Genervon to be given via injections into the bloodstream. While positive results were seen in a Phase 2a trial, its current development status is unknown.

The ALS Association

Established in 1985, The ALS Association (Amyotrophic Lateral Sclerosis Assn) is the only national nonprofit organization fighting ALS on every front.

Kadimastem, NLS merge to advance ALS therapy AstroRx, other drugs

Kadimastem, the developer of the experimental amyotrophic lateral sclerosis (ALS) therapy AstroRx, is merging with NLS Pharmaceutics to combine efforts to advance both companies’ drug portfolios. The combined company will focus on moving AstroRx and a diabetes drug being developed by Kadimastem through clinical trials. A Phase…

Mitochondrial genome mutations linked to ALS in genetic study

Mutations in the mitochondrial genome — the set of DNA instructions found inside mitochondria, the powerhouses of cells — may be linked to amyotrophic lateral sclerosis (ALS), a study found. The findings open the door for new ways of diagnosing and treating the disease, researchers said. “We aren’t saying…